---
title: "GOSR2"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "## Gene Information"
tags: ['GOSR2', 'VesicularTransport', 'EpilepticEncephalopathy', 'MyoclonicEpilepsy', 'CorticalDysplasia', 'GeneticVariations', 'Treatment', 'Prognosis']
---

## Gene Information

**Gene:** GOSR2

**Function:** GOSR2 encodes a protein called Golgi SNAP receptor complex member 2, which is involved in the vesicular transport of molecules through the Golgi apparatus.

**External IDs:**
- HGNC: 4520
- NCBI Entrez: 9578
- Ensembl: ENSG00000120216
- OMIM: 605331
- UniProtKB/Swiss-Prot: O43731

**Aliases:** 
- GOS-28
- GS28

## Genetic Variations

**AA Mutation List:** There are multiple amino acid mutations recorded for GOSR2. Some of them are:

|Mutation|Type|dbSNP ID|
|--------|----|--------|
|A5T|Missense|rs61752315|
|R98W|Missense|rs104894312|
|H118Y|Missense|rs374143112|
|T36A|Missense|rs796491199|

**Somatic SNVs/InDels:** There are several somatic Single Nucleotide Variations (SNVs) and Insertions/Deletions (InDels) recorded for GOSR2. Some of them with dbSNP ID are:

|Mutation Type|dbSNP ID|
|-------------|--------|
|SNV|rs376925003|
|SNV|rs150215157|
|SNV|rs152332221|

## Pathology and Related Diseases

**Related diseases:** Some of the diseases associated with GOSR2 are:
- Epileptic encephalopathy, early infantile, 17 (EIEE17)
- Progressive myoclonic epilepsy 8 (EPM8)
- Cortical dysplasia-focal epilepsy syndrome (CDFES)

## Treatment and Prognosis

There is no known cure for diseases caused by GOSR2 mutations, but certain treatments may help manage the symptoms. The prognosis for individuals with GOSR2-related diseases varies depending on the type and severity of the disease.

## Drug Response

There is no specific drug response recorded for GOSR2.

## Related Papers

- Subject: Early infantile epileptic encephalopathy, GOSR2 mutation, and an attempt at genotype-phenotype correlation.
  - Author(s): Kodera H, Nakamura K, Osaka H, Maegaki Y, Haginoya K, Mizumoto S, Kato M, Okamoto N, Iai M, Kondo Y, Nishiyama K, Tsurusaki Y, Nakashima M, Miyake N, Hayasaka K, Matsumoto N, Saitsu H.
  - DOI: 10.1111/epi.12477
  
- Subject: De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies.
  - Author(s): Epi4K consortium., Epilepsy Phenome/Genome Project., Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marzec J, Miller JK, Modave F, Montgomery KT, Murrell JR, Parisi MA, Petrou S, Pitk√§nen A, Reutens DC, Richardson MP, Sadleir LG, Scheffer IE, Schneider W, Slifer KJ, Suls A, Takeuchi T, Thiele EA, Wang Y, Wimmer V, Consortium E, Silverstein S, White PS, Johnson J, Wisoff JH, Ottman R, Hauser WA, Xu H, Dessureau J, McNamara JO, Mulley JC, Nabbout R, Dindorf G, Ostertag P, Jayewardene AK, Dixon-Salazar T, Scheffer IE, Berkovic SF, Dibbens LM.
  - DOI: 10.1038/nature12439

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**